Cited by 245Thyroid Disorders and TreatmentsHeart Failure Treatment and ManagementHormonal and reproductive studies

Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes

Open access
Kannan, Lakshmi, Shaw, Pamela A., Morley, Michael P., Brandimarto, Jeffrey, Fang, James C., Sweitzer, Nancy K., Cappola, Thomas P., Cappola, Anne R.·2018·Circulation: Heart Failure

Abstract

Background: The effects of thyroid dysfunction in patients with preexisting heart failure have not been adequately studied. We examined the prevalence of thyroid dysfunction and associations with cardiovascular outcomes in a large, prospective cohort of outpatients with preexisting heart failure. Methods and Results: We examined associations between thyroid dysfunction and New York Heart Association class, atrial fibrillation, and a composite end point of ventricular assist device placement, heart transplantation, or death in 1365 participants with heart failure enrolled in the Penn Heart Failure Study. Mean age was 57 years, 35% were women, and the majority had New York Heart Association class II (45%) or III (32%) symptoms. More severe heart failure was associated with higher thyroid-stimulating hormone (TSH), higher free thyroxine (FT4), and lower total triiodothyronine (TT3) concentrations ( P <0.001 all models). Atrial fibrillation was positively associated with higher levels of FT4 alone ( P ≤0.01 all models). There were 462 composite end points over a median 4.2 years of follow-up. In adjusted models, compared with euthyroidism, subclinical hypothyroidism (TSH 4.51–19.99 mIU/L with normal FT4) was associated with an increased risk of the composite end point overall (hazard ratio, 1.82; 95% CI, 1.27–2.61; P =0.001) and in the subgroup with TSH ≥7.00 mIU/L (hazard ratio, 3.25; 95% CI, 1.96–5.39; P <0.001), but not in the subgroup with TSH 4.51–6.99 mIU/L (hazard ratio, 1.26; 95% CI, 0.78–2.06; P =0.34). Isolated low T3 was also associated with the composite end point (hazard ratio, 2.12; 95% CI, 1.65–2.72; P <0.001). Conclusions: In patients with preexisting heart failure, subclinical hypothyroidism with TSH ≥7 mIU/L and isolated low T3 levels are associated with poor prognosis. Clinical trials are needed to explore therapeutic effects of T4 and T3 administration in heart failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.118.005266

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In humans, hypothyroidism is associated with a poor prognosis in established heart failure.

    “In humans, hypothyroidism is associated with a poor prognosis in established heart failure (33) and TH can reduce intrahepatic triglyceride content (34,35).”

    From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [33]

    The Conclusions and Discussion report poor outcomes in ambulatory patients with established heart failure who had subclinical hypothyroidism with TSH ≥ 7 mIU/L. The claim omits that threshold and thus implies the association applies to hypothyroidism generally; the Discussion says it was not found for TSH < 7 mIU/L. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • In humans, hypothyroidism is associated with a poor prognosis in established heart failure.

    “In humans, hypothyroidism is associated with a poor prognosis in established heart failure [33]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kannan, L., Shaw, P. A., Morley, M. P., Brandimarto, J., Fang, J. C., Sweitzer, N. K., Cappola, T. P., & Cappola, A. R.
Affiliations
  • University of Pennsylvania (US)
  • University of Utah (US)
  • University of Arizona (US)
Venue
Circulation: Heart Failure
Published
2018-12
Volume
11
Issue
12
Pages
e005266-e005266
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2904496087
Cited by
245
References
33
Citations by year
2026: 17 · 2025: 27 · 2024: 40 · 2023: 50 · 2022: 32 · 2021: 37 · 2020: 28 · 2019: 13 · 2018: 1
FWCI
15.70
Type
journal article
Language
en
Open access
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • BG Medicine
  • National Institute on Aging (K24AG042765)
  • National Heart, Lung, and Blood Institute (R01HL088577)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
heart failure, subclinical hypothyroidism, thyroid-stimulating hormone, free thyroxine, triiodothyronine, atrial fibrillation, cardiovascular outcomes, mortality, heart transplantation, ventricular assist devices, prognosis
MeSH terms
Adult, Aged, Female, Heart Failure, Humans, Hypothyroidism, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Severity of Illness Index, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine, Time Factors, Triiodothyronine, United States, Biomarkers, Comorbidity, Prevalence, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review